US Stock MarketDetailed Quotes

GTBP GT Biopharma

Watchlist

2.8000
-0.0600-2.10%

Close Nov 29 13:00 ET

2.8000
0.00000.00%

Post 17:01 ET

6.26MMarket Cap-375P/E (TTM)

GT Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

15.44%3.6M

7.87%3.91M

-15.66%3.09M

-36.13%13.58M

-45.17%3.17M

-55.55%3.12M

20.14%3.62M

-32.65%3.67M

-63.04%21.26M

-68.21%5.78M

Selling and administrative expenses

30.66%2.3M

39.06%2.12M

14.84%2.31M

-42.87%7.11M

-38.32%1.81M

-58.93%1.76M

-18.61%1.53M

-39.94%2.02M

-74.03%12.45M

-75.27%2.94M

-General and administrative expense

----

39.06%2.12M

----

-18.61%1.53M

----

Research and development costs

-4.18%1.31M

-14.84%1.78M

-52.91%777K

-26.61%6.47M

-52.25%1.36M

-50.27%1.36M

83.93%2.1M

-20.94%1.65M

-8.13%8.81M

-54.92%2.84M

Operating profit

-15.44%-3.6M

-7.87%-3.91M

15.66%-3.09M

36.13%-13.58M

45.17%-3.17M

55.55%-3.12M

-20.14%-3.62M

32.65%-3.67M

63.04%-21.26M

68.21%-5.78M

Net non-operating interest income expense

-55.56%96K

-52.05%105K

395.83%142K

99.65%567K

35.34%180K

101.87%216K

508.33%219K

-700.00%-48K

141.76%284K

931.25%133K

Non-operating interest income

-55.56%96K

-52.27%105K

-13.41%142K

167.12%780K

27.66%180K

101.87%216K

511.11%220K

1,950.00%164K

668.42%292K

2,250.00%141K

Non-operating interest expense

--0

2,562.50%213K

--0

--1K

--212K

-98.89%8K

-63.64%8K

Other net income (expense)

-80.20%97K

-93.55%91K

-80.41%683K

5,980.90%5.41M

-57.38%26K

1,300.00%490K

141,100.00%1.41M

58,200.00%3.49M

-51.10%89K

-64.53%61K

Gain on sale of security

-80.20%97K

-91.55%118K

-77.79%656K

5,343.82%4.85M

-90.16%6K

1,300.00%490K

139,700.00%1.4M

49,316.67%2.95M

-51.10%89K

-64.53%61K

Special income (charges)

--0

--547K

--0

--14K

--533K

--0

-Less:Other special charges

----

---547K

--0

----

---14K

---533K

----

Other non- operating income (expenses)

----

---27K

--27K

--20K

----

Income before tax

-41.18%-3.41M

-86.24%-3.71M

-898.24%-2.27M

63.62%-7.6M

46.96%-2.96M

64.89%-2.42M

33.13%-1.99M

95.83%-227K

64.00%-20.88M

69.02%-5.58M

Income tax

Net income

-41.18%-3.41M

-86.24%-3.71M

-898.24%-2.27M

63.62%-7.6M

46.96%-2.96M

64.89%-2.42M

33.13%-1.99M

95.83%-227K

64.00%-20.88M

69.02%-5.58M

Net income continuous Operations

-41.18%-3.41M

-86.24%-3.71M

-898.24%-2.27M

63.62%-7.6M

46.96%-2.96M

64.89%-2.42M

33.13%-1.99M

95.83%-227K

64.00%-20.88M

69.02%-5.58M

Minority interest income

Net income attributable to the parent company

-41.18%-3.41M

-86.24%-3.71M

-898.24%-2.27M

63.62%-7.6M

46.96%-2.96M

64.89%-2.42M

33.13%-1.99M

95.83%-227K

64.00%-20.88M

69.02%-5.58M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-41.18%-3.41M

-86.24%-3.71M

-898.24%-2.27M

63.62%-7.6M

46.96%-2.96M

64.89%-2.42M

33.13%-1.99M

95.83%-227K

64.00%-20.88M

69.02%-5.58M

Basic earnings per share

13.56%-1.53

-45.64%-2.17

-680.95%-1.64

71.31%-5.5836

58.26%-2.1136

73.18%-1.77

50.33%-1.49

95.88%-0.21

68.51%-19.4634

67.54%-5.0634

Diluted earnings per share

13.56%-1.53

-45.64%-2.17

-680.95%-1.64

71.31%-5.5836

58.26%-2.1136

73.18%-1.77

50.33%-1.49

95.88%-0.21

68.51%-19.4634

67.54%-5.0634

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	15.44%3.6M	7.87%3.91M	-15.66%3.09M	-36.13%13.58M	-45.17%3.17M	-55.55%3.12M	20.14%3.62M	-32.65%3.67M	-63.04%21.26M	-68.21%5.78M
Selling and administrative expenses	30.66%2.3M	39.06%2.12M	14.84%2.31M	-42.87%7.11M	-38.32%1.81M	-58.93%1.76M	-18.61%1.53M	-39.94%2.02M	-74.03%12.45M	-75.27%2.94M
-General and administrative expense	----	39.06%2.12M	----	----	----	----	-18.61%1.53M	----	----	----
Research and development costs	-4.18%1.31M	-14.84%1.78M	-52.91%777K	-26.61%6.47M	-52.25%1.36M	-50.27%1.36M	83.93%2.1M	-20.94%1.65M	-8.13%8.81M	-54.92%2.84M
Operating profit	-15.44%-3.6M	-7.87%-3.91M	15.66%-3.09M	36.13%-13.58M	45.17%-3.17M	55.55%-3.12M	-20.14%-3.62M	32.65%-3.67M	63.04%-21.26M	68.21%-5.78M
Net non-operating interest income expense	-55.56%96K	-52.05%105K	395.83%142K	99.65%567K	35.34%180K	101.87%216K	508.33%219K	-700.00%-48K	141.76%284K	931.25%133K
Non-operating interest income	-55.56%96K	-52.27%105K	-13.41%142K	167.12%780K	27.66%180K	101.87%216K	511.11%220K	1,950.00%164K	668.42%292K	2,250.00%141K
Non-operating interest expense	--0	--0	--0	2,562.50%213K	--0	--0	--1K	--212K	-98.89%8K	-63.64%8K
Other net income (expense)	-80.20%97K	-93.55%91K	-80.41%683K	5,980.90%5.41M	-57.38%26K	1,300.00%490K	141,100.00%1.41M	58,200.00%3.49M	-51.10%89K	-64.53%61K
Gain on sale of security	-80.20%97K	-91.55%118K	-77.79%656K	5,343.82%4.85M	-90.16%6K	1,300.00%490K	139,700.00%1.4M	49,316.67%2.95M	-51.10%89K	-64.53%61K
Special income (charges)	--0	--0	--0	--547K	--0	--0	--14K	--533K	--0	--0
-Less:Other special charges	----	----	----	---547K	--0	----	---14K	---533K	----	----
Other non- operating income (expenses)	----	---27K	--27K	--20K	----	----	----	----	----	----
Income before tax	-41.18%-3.41M	-86.24%-3.71M	-898.24%-2.27M	63.62%-7.6M	46.96%-2.96M	64.89%-2.42M	33.13%-1.99M	95.83%-227K	64.00%-20.88M	69.02%-5.58M
Income tax
Net income	-41.18%-3.41M	-86.24%-3.71M	-898.24%-2.27M	63.62%-7.6M	46.96%-2.96M	64.89%-2.42M	33.13%-1.99M	95.83%-227K	64.00%-20.88M	69.02%-5.58M
Net income continuous Operations	-41.18%-3.41M	-86.24%-3.71M	-898.24%-2.27M	63.62%-7.6M	46.96%-2.96M	64.89%-2.42M	33.13%-1.99M	95.83%-227K	64.00%-20.88M	69.02%-5.58M
Minority interest income
Net income attributable to the parent company	-41.18%-3.41M	-86.24%-3.71M	-898.24%-2.27M	63.62%-7.6M	46.96%-2.96M	64.89%-2.42M	33.13%-1.99M	95.83%-227K	64.00%-20.88M	69.02%-5.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-41.18%-3.41M	-86.24%-3.71M	-898.24%-2.27M	63.62%-7.6M	46.96%-2.96M	64.89%-2.42M	33.13%-1.99M	95.83%-227K	64.00%-20.88M	69.02%-5.58M
Basic earnings per share	13.56%-1.53	-45.64%-2.17	-680.95%-1.64	71.31%-5.5836	58.26%-2.1136	73.18%-1.77	50.33%-1.49	95.88%-0.21	68.51%-19.4634	67.54%-5.0634
Diluted earnings per share	13.56%-1.53	-45.64%-2.17	-680.95%-1.64	71.31%-5.5836	58.26%-2.1136	73.18%-1.77	50.33%-1.49	95.88%-0.21	68.51%-19.4634	67.54%-5.0634
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data